Research and Markets (http://www.researchandmarkets.com/research/6whc5l/continuous)
has announced the addition of the "Continuous
Glucose Monitoring Market - Global Industry Analysis, Size, Share,
Growth, Trends and Forecast, 2013 - 2019" report to their
The rapid rise in diabetic population across the globe has considerably
increased the demand for effective diabetes management systems.
Currently, blood glucose meters are widely used for diabetes management;
however, the trend is shifting towards minimally invasive (CGMS) or
noninvasive glucose monitoring systems as these systems reduce the need
for regular finger pricking and also lessen the pain. Continuous glucose
monitoring systems are real time glucose sensing and monitoring devices
that measure and display glucose levels of a patient at regular
The usage of CGM is substantially increasing over traditional glucose
monitoring systems as these systems are user friendly, provide access to
real time values and trend, and provide enhanced accuracy. Additionally,
it has been observed that continuous glucose monitoring significantly
helps in diabetes management especially in type I diabetics, and helps
in reducing long-term complications associated with diabetes. Increasing
awareness in developed and developing economies, technoogical
advancements and rising number of diabetic patients are some of the key
factors that are expected to fuel the growth of this market.
According to International Diabetes Federation (IDF) reports,
approximately 382 million people globally were diagnosed with diabetes
in 2013 and this number is expected to grow to 592 million by 2035.
Additionally, as per Juvenile Diabetes Research Foundation (JDRF), the
prevalence of type I diabetes rose by 23% in the U.S. between 2001 and
2009 for children under 20 years of age and is identified as the seventh
leading cause of death in the country. Hence, rising number of patients
suffering from type I diabetes is likely to increase the demand for CGMS.
The continuous glucose monitoring market has been segmented on the basis
of various CGM systems available in the market including Guardian Real
Time CGM System, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4
Platinum and MiniMed Paradigm Revel/Veo CGM Systems. In 2012, the market
for Guardian Real Time CGM system held the largest share globally,
followed by Dexcom Seven Plus CGM system.
However, during the forecast period 2013 to 2019, growth of the market
for Guardian Real Time CGM system is expected to be slowest due to
market saturation and development of innovative competitor products.
Dexcom G4 Platinum CGM System market is expected to witness the fastest
growth during the forecast period. FreeStyle Navigator that witnessed a
decline in its market share in 2012 due to product recall from the U.S.
market is anticipated to show significant growth during the forecast
period due to expected launch of FreeStyle Navigator ll in 2014 in the
Key Topics Covered:
Continuous Glucose Monitoring (CGM) Market, by Device/Brand, 2011 - 2019
Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011
- 2019 (USD Million)
List of Figures
List of Tables
- Abbott Laboratories
- Bayer AG
- Dexcom, Inc.
- GlySens Incorporated
- Insulet Corporation
- Medtronic, Inc.
- Nova Biomedical Corporation
- Senseonics, Incorporated
For more information visit http://www.researchandmarkets.com/research/6whc5l/continuous
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To NFVZone's Homepage ]